SAN DIEGO (AP) _ Illumina Inc. (ILMN) on Tuesday reported fourth-quarter earnings of $210 million.
The San Diego-based company said it had profit of $1.41 per share. Earnings, adjusted for one-time gains and costs, were $1.32 per share.
The results missed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.36 per share.
The genetic testing tools company posted revenue of $867 million in the period, exceeding Street forecasts. Five analysts surveyed by Zacks expected $864.5 million.
For the year, the company reported profit of $826 million, or $5.56 per share. Revenue was reported as $3.33 billion.
Illumina expects full-year earnings in the range of $6.50 to $6.60 per share.
Illumina shares have decreased almost 5 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $285.26, a climb of 18 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ILMN at https://www.zacks.com/ap/ILMN